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Background: Urinary catheters are associated, commonly with bacteriuria and frequently with urinary tract
infection. Tamm-Horsfall Protein (THP) is urine's most abundant protein and is known to bind to uropathogenic
bacteria. The role of THP in the pathogenesis of catheter associated urinary tract infection (CAUTI) is not clear. We
examined the role of THP in facilitating bacterial binding to urinary catheters in vivo and in vitro.
Findings: Twenty one urinary catheters were obtained from 20 hospitalized patients. THP was eluted from the
catheter surface and catheter segments were cultured. Additional studies were performed in vitro on unused
silicone and latex catheters to determine the binding of THP, and the effect of THP on the binding of Escherichia
coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa), to the catheter surface.
On catheters obtained from patients, the THP deposition was significantly more on culture positive catheters than
on culture negative catheters. In the in vitro studies, THP bound to both silicone and latex catheters, and THP
enhanced the adherence of E. coli and P. aeruginosa to both types of catheters.
Conclusion: THP binds to urinary catheters and facilitates the binding of uropathogenic bacteria to catheters.
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Catheter Associated Urinary Tract Infection (CAUTI) is
a common hospital acquired infection. Urinary catheters
are placed in one of four hospitalized patients in the
United States [1]. About 26% of catheterized patients de-
velop asymptomatic catheter associated bacteriuria
(CAB) of which 24% progress to symptomatic CAUTI
[2]. CAUTI accounts for 40% of all hospital acquired
infections [3,4] and 80% of all hospital acquired urinary
tract infections (UTI) [5]. In adult intensive care units,
more than 95% of urinary tract infections are caused by
urinary catheters [6].
Tamm-Horsfall protein (THP) is the most abundant
protein in normal urine with multiple postulated bio-
logical functions [7-9]. THP is a glycoprotein with a var-
iety of n-linked and o-linked glycans that give it a
versatile ability to bind a variety of substances [7,8]. We
[10] and others [11] have previously shown that THP* Correspondence: satish-kumar@ouhsc.edu
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reproduction in any medium, provided the orplays a defensive role against UTI presumably by bind-
ing uropathogenic bacteria and helping to clear them
from the urinary tract.
The role of THP as a host defense factor against UTI
has not been studied in the presence of an in-dwelling
urinary catheter. The abundance of THP in urine and its
tendency to bind a variety of surfaces make it likely that
it would bind to the surface of urinary catheters. We
hypothesized that the presence of a catheter in the urin-
ary tract may reverse the normal role of THP. Normally
– in the absence of a catheter – THP acts as a host
defense factor against UTI. The presence of a catheter,
however, could allow THP to bind to the catheter sur-
face and form a conditioning layer that could allow
binding of bacteria and formation of a bacterial biofilm.
Bacteria could multiply undisturbed in the biofilm [12]
and be released into the urine upon reaching an ad-
equate density, perpetuating bacterial presence in the
urine.
At present, it is not known if THP sticks to urinary
catheters and if it affects the binding of bacteria to the
catheter surface. In the present study, we determined
the effect of THP on binding of uropathogenic bacteria. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in the United States. Urinary catheters collected from
patients were examined for THP and bacterial adher-
ence. In the in vitro studies, silicone and latex catheters
were examined for adsorption of THP and the effect of
THP on the adherence of two types of uropathogenic
bacteria to the catheter surface.
Methods
Human studies
Twenty one urinary catheters (17 latex and 4 silicone)
were collected aseptically from 20 patients after approval
from the institutional review board of The University of
Oklahoma Health Sciences Center, Oklahoma City, OK.
The catheter insertion and removal was performed as
considered necessary for the routine clinical care by the
treating physicians. The catheters were cut into 1 cm
segments starting at the catheter tip. One segment was
used for quantitation of THP binding and another for
bacterial culture. Bacteria were dislodged from the cath-
eter section by sonication and cultured on blood and
MacConkey agars. Bacterial isolates were speciated with
the Vitek 2 System (bioMerieux, Inc., Durham, NC)
using colorimetric technology. THP was eluted from
catheter segments by incubation in TEA buffer (0.5%
Triton-X 100/20 mM EDTA/pH 7.5) and quantitated by
ELISA.
In-vitro studies
Human urine was collected in a sterile container and
tested for sterility on MacConkey agar. One half of the
urine specimen was filtered through a 0.2 μ filtration
unit (Nalgene, Rochester, NY) to remove THP. The
whole and filtered urine specimens were analyzed for
THP by ELISA and polyacrylamide gel electrophoresis
followed by silver staining and Western Blot.
THP binding experiments
Bardex Infection Control (latex) and Lubri-Sil Infection
Control (silicone), 20 French catheters were cut into 1-
cm segments. The catheter segments were incubated in
40 ml of whole or filtered urine, in 50 ml sterile conical
centrifuge tubes. The tubes were rotated at 37°C and the
solutions were changed daily. Three catheter segments
were removed at 9, 12 and 24 hrs and on days 7, 14 and
30, and rinsed in phosphate buffered saline (PBS). THP
bound to the catheter segments was extracted in TEA
buffer and quantitated by ELISA.
Bacterial adherence experiments
Escherichia coli (E. coli) strain UTI89 (a clinical cystitis
strain mainly expressing type 1 fimbriae) and Pseudo-
monas aeruginosa (P. aeruginosa, American Type Cul-
ture Collection # 27314) were grown in Tryptose Brothand Brain Heart Infusion Broth, respectively. The con-
centration of E.coli in the broth was measured by culture
of serial dilutions of the broth on Eosin Methylene Blue
(EMB) agar and that of P. aeruginosa on Columbia
Blood Base Agar. The bacteria were grown for 24 hours
at 37°C with 5 uCi/ml of methyl-3H Thymidine (64 Ci/
mmol specific activity). The radiolabeled bacteria were
washed in Dulbecco's phosphate buffered saline (DPBS)
and resuspended at a concentration of 1x108 CFU/ml, in
artificial urine [13] or artificial urine with 0.1 mg/ml
THP. The bacterial solutions were incubated with 1-cm
sections of the latex and silicone catheters at 37°C.
Three sections were removed from each tube at 1, 6 and
24 hrs, and washed with DPBS. Bacterial binding to the
catheter segments was measured by scintillation count-
ing. On days 2, 4 and 7, three sections were removed
from each tube, and sonicated in DPBS to dislodge the
bacteria. The bacteria were quantitated by culture of ser-
ial dilutions on agar.
Statistical analysis
The data were expressed as the mean + SE and com-
pared statistically using Student’s t-test. Statistical signifi-
cance was set at P < 0.05.
Findings
Human studies
Cultures of catheter segments were positive in 16 (15 latex
and 1 silicone) and negative in 5 (2 latex and 3 silicone)
catheters. The organisms isolated and the number of cul-
ture positive catheters were: Escherichia coli, 3; Entero-
coccus fecium, 3; Enterococcus faecalis, 5; Staphylococcus
epidermidis, 4; Candida albicans, 1; Staphylococcus homi-
nis, 1; Klebsiella pneumoniae, 1; Staphylococcus aureus, 1;
Enterobacter sakazakii, 1 and Staphylococcus warneri, 1;
some catheters had multiple organisms. The THP depos-
ition was significantly more on culture positive catheters
than on culture negative catheters (8990 ng THP/cm+
4301 vs. 865 ng THP/cm+513, respectively; P = 0.039)
(Figure 1).
In-vitro studies
Both silicone and latex urinary catheters were quickly
and equally coated with THP from the first time point at
9 hrs (silicone, 370 ng/cm+ 65 and latex, 456 ng/cm+
155). At later time points, more THP was found bound
to the silicone catheters than to the latex catheters re-
spectively: 12 hr (142 ng/cm+ 15 vs 46 ng/cm+ 37,
P = 0.001), day 1 (120 ng/cm+ 4 vs 37 ng/cm+5,
P = 0.00001), day 7 (160 ng/cm+ 33 vs 26 + 5 ng/cm + ,
P = 0.003), day 14 (275 ng/cm+ 41 vs 84 ng/cm+ 4,
P = 0.002) and day 30 (107 ng/cm+32 vs 15 ng/cm+ 5,
P =0.014). THP binding to urinary catheters increased
further after 7 days of incubation (Figure 2).
Figure 1 Distribution of catheter THP concentration and catheter bacterial culture analysis (positive or negative). The bacterial culture
positive catheters had significantly more THP on the catheter surface. * indicates the mean.
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in the artificial urine with THP versus artificial urine
without THP was greater to the silicone catheter at 1 hr
(6.25 + 0.17 vs 5.73 + 0.07, P = 0.02), 6 hr (6.08 + 0.04 vs
5.67 + 0.13, P = 0.02), day 1 (6.1 + 0.02 vs 5.57 + 0.02,
P = 0.00004) and day 7 (4.2 + 0.2 vs 2.9 + 0.2, P = 0.005)
and to the latex catheter at 6 hr (5.95 + 0.06 vs
5.68 + 0.05, P = 0.01) than in artificial urine alone. P.
aeruginosa adherence was more to the latex catheter at
2 days (6.7 + 0.03 vs 6.4 + 0.01, P = 0.0003), and to the
silicone catheter at 7 days (4.0 + 0.2 vs 2.8 + 0.4, P = 0.03)Figure 2 Time Course of THP adsorption to latex and silicone
urinary catheters. THP adsorption increased on both types of
catheters after 7 days. THP adsorption was more on silicone
catheters.in the artificial urine with THP versus the artificial urine
alone.
Discussion
The urinary tract is normally sterile. Insertion of a blad-
der catheter invades this sterile space and provides an
opportunity for infection. E.coli accounts for about 25-
50% of the cases of CAUTI. Other species isolated fre-
quently are Proteus, Klebsiella, Enterococcus, Pseudo-
monas and Staphylococcus [14,15]. These bacteria are
normally resident in the colon and frequently colonize
the periurethral space. They ascend up the catheters into
the urinary bladder on the external surface of the cath-
eter in 66% and on the lumen of the catheter in 34% of
the cases [16]. For CAUTI to occur, the bacteria need to
adhere to the catheter, have an opportunity to multiply,
evade normal urinary defense factors and invade the
bladder epithelium.
THP has long been postulated to play a role in binding
free floating (planktonic) bacteria in the urine and in
aiding their excretion to help maintain the sterility of
the urinary tract [17]. In vitro studies have demonstrated
binding between E. coli and THP that was mediated by
the binding of type 1 fimbriae on the surface of E. coli to
the high-mannose structure present on THP [18]. The
role of THP as a urinary defense factor was highlighted
when we and others created THP gene knockout mice
and demonstrated that THP-deficient mice had difficulty
clearing E. coli from the urinary tract [10,11]. Subse-
quently, we extended these findings to include other
uropathogenic bacteria such as Klebsiella pneumonia,
Staphylococcus saprophyticus, [19] and Proteus mirabilis
[20]. In a study examining 51 long term catheterized
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than 2 weeks expressed type 1 fimbriae more frequently
and bound more THP than bacterial isolates from UTI
episodes lasting 1 week or less [21]. These data sug-
gested that binding between type 1 fimbriae and THP
could have contributed to the persistence of CAUTI.
In our clinical study, all catheters were found to be
coated with THP and the amount of THP adsorbed was
higher on culture positive catheters. In our in vitro stud-
ies, THP bound to both latex and silicone urinary cathe-
ters and facilitated the binding of E. coli and P.
aeruginosa to both types of catheters. THP binding to
urinary catheters increased after 7 days.
These data suggest that THP which serves as a host
defense factor against UTI in the absence of an indwel-
ling urinary catheter may have the opposite effect of
promoting bacterial presence in urine in the presence of
a urinary catheter and that catheter removal or change
at 7 days may help prevent CAUTI. The major limitation
of this study is the small sample size. These data need to
be confirmed in larger studies before routine change of
catheters at 7 days can be recommended as a practice
guideline.
Conclusion
THP, a normal host defense factor against UTI, may
have a paradoxical effect of promoting UTI in the pres-
ence of indwelling urinary catheters.
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